Theravance, Inc. (THRX) Reports Q4 Loss of $0.45, Sales Fall Short
THRX Hot Sheet
EPS Growth %: +432.1%Financial Fact:
Interest expense: -1.5M
Today's EPS Names:
TARO, BRLI, TLB, More
Theravance, Inc. (NASDAQ: THRX) reported Q4 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $6.87 million.
For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Nomura Securities Upgrades ASML Inc. (ASML) to Buy; Revenue Outlook Underestimated
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
